Jeong Heo
Pusan National University
H-index: 46
Asia-South Korea
Top articles of Jeong Heo
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with … | Riccardo Lencioni Masatoshi Kudo Joseph Erinjeri Shukui Qin Zhenggang Ren | 2024/1/20 | |
First safety and efficacy data from phase Ib/IIa study of fostroxacitabine bralpamide (fostrox, MIV-818) in combination with lenvatinib in patients with hepatocellular … | Maria Reig TR Jeffry Evans Hong Jae Chon Ho Yeong Lim Min-Hee Ryu | 2024/1/20 | |
Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma | Cancers | Sang Youn Hwang Hyun Young Woo Jeong Heo Hyung Jun Kim Young Joo Park | 2024/1 |
Pegylated interferon reduces relapses following bepirovirsen treatment in participants with chronic hepatitis B virus infection on nucleos (t) ide analogues: end of study … | Zeitschrift für Gastroenterologie | Maria Buti Jeong Heo Yasuhito Tanaka Pietro Andreone Masanori Atsukawa | 2024/1 |
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma | Annals of Oncology | B Sangro SL Chan RK Kelley G Lau M Kudo | 2024/2/19 |
Navigating through the PD-1/PDL-1 landscape: A systematic review and meta-analysis of clinical outcomes in hepatocellular carcinoma and their influence on immunotherapy and … | Muhammad Joan Ailia Jeong Heo So Young Yoo | 2023/3/30 | |
Abstract CT003: IMbrave050: Phase 3 study of adjuvant atezolizumab+ bevacizumab versus active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of … | Cancer Research | Pierce Chow Minshan Chen Ann-Lii Cheng Ahmed O Kaseb Masatoshi Kudo | 2023/5/29 |
Erratum: Correction of Text in the Article “Seroprevalence of Hepatitis C Virus Infection in North Korean Defectors Residing in Korea” | Journal of Korean Medical Science | Young Mi Hong Ki Tae Yoon Young Joo Park Hyun Young Woo Jeong Heo | 2023/9/9 |
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma | Liver Cancer | Ghassan K Abou-Alfa Peter R Galle Yee Chao Joseph Erinjeri Jeong Heo | 2023 |
IMbrave050: Phase 3 study of adjuvant atezolizumab+ bevacizumab versus active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence … | American Association for Cancer Research (AACR) Annual Conference | Pierce Chow Minshan Chen Ann-Lii Cheng Ahmed Kaseb Masatoshi Kudo | 2023/4/14 |
Seroprevalence of Hepatitis C Virus Infection in North Korean Defectors Residing in Korea | Nigerian journal of clinical practice | OA Adegoke BA Kolawole RT Ikem A Adediran AO Aboderin | 2008/12/11 |
Abstract CT150: Result of an open-label phase 2 trial of dual TORC1/TORC2 inhibitor onatasertib (ATG-008) in HBV+ advanced hepatocellular carcinoma (HCC) subjects who have … | Cancer Research | Shukui Qin Xiaoyan Lin Zhiqaing Meng Zhenggang Ren Yuxian Bai | 2023/4/14 |
Preliminary safety and antiviral activity of AB-729 combination treatment with pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV … | Man-Fung Yuen Jeong Heo Ronald G Nahass Grace Lai-Hung Wong Tatiana Burda | 2023 | |
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial | Molecular Therapy | Jeong Heo Ja-Der Liang Chang Won Kim Hyun Young Woo I-Lun Shih | 2023/7/5 |
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Journal of Hepatology | Lung-Yi Mak Ed Gane Christian Schwabe Ki Tae Yoon Jeong Heo | 2023/4/1 |
Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study | The Korean Journal of Internal Medicine | Jeong Heo Yoon Jun Kim Sung Wook Lee Youn-Jae Lee Ki Tae Yoon | 2023/7 |
Oncolytic virotherapy targeting the IL15 pathway | Molecular Therapy-Oncolytics | So Young Yoo Jeong Heo | 2023/12/19 |
Response-guided therapy with cefotaxime, ceftriaxone, or ciprofloxacin for spontaneous bacterial peritonitis: A randomized trial: A validation study of 2021 AASLD practice … | Official journal of the American College of Gastroenterology| ACG | Hyung Joon Yim Tae Hyung Kim Sang Jun Suh Sun Young Yim Young Kul Jung | 2023/4/1 |
Provisional Provisional | J Korean Med Sci | Seung-Ah Choe Kunwoo Kim Hyun-Joo Seol Ji Yeon Lee Min-A Kim | 2020/10/19 |
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label … | The Lancet | Shukui Qin Minshan Chen Ann-Lii Cheng Ahmed O Kaseb Masatoshi Kudo | 2023/11/18 |
Co-Authors
